Literature DB >> 8153306

Chronic pulmonary thromboembolism: detection of regional hypoperfusion with CT.

M A King1, C J Bergin, D W Yeung, E E Belezzouli, L K Olson, W L Ashburn, W R Auger, K M Moser.   

Abstract

PURPOSE: To study the relationship of regional hypoperfusion and areas of decreased lung attenuation on computed tomographic (CT) scans of patients with chronic pulmonary thromboembolism.
MATERIALS AND METHODS: Preoperative CT scans of five patients (four men and one woman, aged 29-72 years) with chronic pulmonary thromboembolism were reviewed and compared with axial single photon emission CT (SPECT) perfusion scans obtained at similar levels. Regions of varying attenuation and perfusion were scored on a three-point scale.
RESULTS: In the five patients, 198 regions were identified. Of 176 abnormal regions at SPECT, 133 were abnormal at CT (sensitivity, 75.6%). Eleven of 22 regions interpreted as normal at SPECT were judged to have normal attenuation at CT (specificity, 50%). The overall accuracy of CT for detecting areas of hypoperfusion was 72.7% (P = .011).
CONCLUSION: A mosaic pattern of lung attenuation at CT is a sign of variable regional perfusion and may suggest chronic pulmonary thromboembolism as a cause for pulmonary hypertension.

Entities:  

Mesh:

Year:  1994        PMID: 8153306     DOI: 10.1148/radiology.191.2.8153306

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  9 in total

Review 1.  CT imaging of peripheral pulmonary vessel disease.

Authors:  Arnaud Resten; Sophie Maitre; Dominique Musset
Journal:  Eur Radiol       Date:  2005-05-20       Impact factor: 5.315

2.  CT of the chest in the evaluation of idiopathic pulmonary arterial hypertension in children.

Authors:  Gulraiz Chaudry; Cathy MacDonald; Ian Adatia; Munire Gundogan; David Manson
Journal:  Pediatr Radiol       Date:  2007-02-06

3.  Chronic Pulmonary Embolism Mimicking Pulmonary Angiosarcoma.

Authors:  Juan Carlos Leandro Perez Lozada; Guy Torstenson
Journal:  Radiol Case Rep       Date:  2015-12-07

Review 4.  Chronic pulmonary embolism: diagnosis.

Authors:  Katia Hidemi Nishiyama; Sachin S Saboo; Yuki Tanabe; Dany Jasinowodolinski; Michael J Landay; Fernando Uliana Kay
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

5.  Use of computed tomography and automated software for quantitative analysis of the vasculature of patients with pulmonary hypertension.

Authors:  Danilo Tadao Wada; Adriana Ignácio de Pádua; Moyses Oliveira Lima Filho; José Antonio Marin Neto; Jorge Elias Júnior; José Baddini-Martinez; Marcel Koenigkam Santos
Journal:  Radiol Bras       Date:  2017 Nov-Dec

6.  Mosaic Pattern of Lung Attenuation on Chest CT in Patients with Pulmonary Hypertension.

Authors:  Kamonpun Ussavarungsi; Augustine S Lee; Charles D Burger
Journal:  Diseases       Date:  2015-09-07

7.  Involvement of the pulmonary arteries in patients with Takayasu arteritis: a prospective study from a single centre in China.

Authors:  Xiufang Kong; Lili Ma; Peng Lv; Xiaomeng Cui; Rongyi Chen; Zongfei Ji; Huiyong Chen; Jiang Lin; Lindi Jiang
Journal:  Arthritis Res Ther       Date:  2020-06-05       Impact factor: 5.156

8.  EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI).

Authors:  David G Kiely; David Levin; Paul Hassoun; David D Ivy; Pei-Ni Jone; Jumaa Bwika; Steven M Kawut; Jim Lordan; Angela Lungu; Jeremy Mazurek; Shahin Moledina; Horst Olschewski; Andrew Peacock; Goverdhan Dutt Puri; Farbod Rahaghi; Michal Schafer; Mark Schiebler; Nicholas Screaton; Merryn Tawhai; Edwin Jr Van Beek; Anton Vonk-Noordegraaf; Rebecca R Vanderpool; John Wort; Lan Zhao; Jim Wild; Jens Vogel-Claussen; Andrew J Swift
Journal:  Pulm Circ       Date:  2019-03-18       Impact factor: 3.017

Review 9.  Computed tomography appearances of the lung parenchyma in pulmonary hypertension.

Authors:  Robert W Foley; Nirav Kaneria; Rob V MacKenzie Ross; Jay Suntharalingam; Benjamin J Hudson; Jonathan Cl Rodrigues; Graham Robinson
Journal:  Br J Radiol       Date:  2020-09-11       Impact factor: 3.039

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.